Subang Jaya Medical Centre Applauded by Frost & Sullivan for Its Leadership Position in the Malaysian Hospital Industry
SJMC is well positioned to drive the private hospital space into its next growth phase, capturing market share and sustaining its leadership in the coming years. SAN ANTONIO, July 13, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the Malaysian hospital industry and, based on its analysis results, recognizes Subang Jaya Medical Centre (SJMC)...
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
TEL AVIV, Israel, July 13, 2022 /PRNewswire/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of hypertensive disorders, announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved Pilot study to treat Hypertension (the...
EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region
CHICAGO and SINGAPORE, July 13, 2022 /PRNewswire/ -- EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and other countries in the area, and Compai Pharma, an enterprising pharmaceutical company offering full-service commercialisation with offices in...
GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies
SEOUL, South Korea, July 12, 2022 /PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T cell therapy platform targeting solid cancer, announced that they had entered into a strategic partnership MOU concerning the development of...
Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31
HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The...
lavojoy Announced New Partnership with Australian Leading Therapeutic Expert Ron Guba
SYDNEY, July 13, 2022 /PRNewswire/ -- lavojoy, a new personal care brand, recently announced its new partnership with Ron Guba, the former chief formulator of a well-known luxury washing and care brand in Australia. Since April 2022, he has cooperated closely with lavojoy team as the formulator to deliver better products to the public. Ron Guba is Australia's leading expert in...
Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176 at the World Conference of Lung Cancer
The abstract suggests that BBT-176 has shown its capability of inducing clinical tumor responses in EGFR triple mutation-containing patients Further exploration of the drug efficacy and safety profiles at RP2D is planned The abstract is now available on the IASLC 2022 WCLC website SEONGNAM, South Korea, July 13, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South...
Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor
TAIPEI, July 12, 2022 /PRNewswire/ -- Flat Medical Co., Ltd., a MedTech company specializing in safety solutions for anesthesia and critical care procedures, announced that it has received Medical Device Regulation (MDR) certification from its Notified Body, the British Standards Institution (BSI), for its brand-new innovation, EpiFaith® CV, to deliver safe central line placements in European markets. "This...
Discovery Life Sciences Acquires AllCells
CREATES PREMIER GLOBAL PROVIDER OF CRITICAL STARTING MATERIALS AND ANALYTIC SERVICES TO ACCELERATE CELL AND GENE THERAPY APPLICATIONS HUNTSVILLE, Ala. and ALAMEDA, Calif., July 12, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research...
National Comprehensive Cancer Network Shares New Recommendations for Treating Children with Brain Tumors
Newly-published NCCN Guidelines for Pediatric Central Nervous System Cancers synthesize latest evidence to help care teams ensure children with high-grade gliomas have best possible outcomes; available free at NCCN.org. PLYMOUTH MEETING, Pa., July 12, 2022 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®) published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Central Nervous...
